Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
02/17/2005 | WO2005014579A1 Imidazol derivatives of piperdine as histamine antagonists |
02/17/2005 | WO2005014555A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
02/17/2005 | WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
02/17/2005 | WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
02/17/2005 | WO2005013985A1 Treatment for alzheimer's disease and related conditions |
02/17/2005 | WO2005013979A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | WO2005013978A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | WO2005013976A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
02/17/2005 | WO2004094386A8 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
02/17/2005 | WO2004084813A3 Chemical compounds |
02/17/2005 | WO2004063330A3 (2-carboxamido) (3-amino) thiophene compounds |
02/17/2005 | US20050038246 PPAR active compounds |
02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
02/17/2005 | US20050038104 Substitute benzothiophene compounds |
02/17/2005 | US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
02/17/2005 | US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia |
02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
02/17/2005 | US20050038051 Novel molecules for regulating cell death |
02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
02/17/2005 | US20050038025 Thioarabinofuranosyl compounds and use thereof |
02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
02/17/2005 | US20050037925 Mixture with other herbicides |
02/17/2005 | DE10328533A1 New 6-amino-substituted indolinone derivatives, useful e.g. for treating tumours and angiogenesis, are inhibitors of receptor tyrosine kinases |
02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
02/17/2005 | CA2534240A1 Treatment for alzheimer's disease and related conditions |
02/17/2005 | CA2534136A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | CA2534098A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | CA2534057A1 Novel gamma-secretase inhibitors |
02/17/2005 | CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | CA2533970A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/17/2005 | CA2532910A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
02/17/2005 | CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
02/16/2005 | EP1506777A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient |
02/16/2005 | EP1506190A1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker |
02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
02/16/2005 | EP1506185A1 Novel compounds and their use |
02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
02/16/2005 | EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
02/16/2005 | CN1582284A Aminopyrimidines and pyridines |
02/16/2005 | CN1582283A Benzothiepine ileal bile acid transport inhibitors |
02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
02/16/2005 | CN1582275A Calcium antagonistic compound |
02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
02/16/2005 | CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
02/15/2005 | US6855730 3-methylidenyl-2-indolinone modulators of protein kinase |
02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
02/15/2005 | US6855714 For therapy of inflammatory, allergic, infectious or autoimmune diseases |
02/15/2005 | US6855713 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
02/15/2005 | CA2107223C Crystalline tiagabine hydrochloride monohydrate, its preparation and use |
02/10/2005 | WO2005012291A1 3-amino choman and 2-amino tetralin derivatives |
02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
02/10/2005 | WO2005012283A1 Substituted benzothiophene compounds and uses thereof |
02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
02/10/2005 | WO2005011700A1 INHIBITORS OF Akt ACTIVITY |
02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
02/10/2005 | WO2005011646A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
02/10/2005 | WO2004099191A3 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors |
02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
02/10/2005 | US20050033057 Thiazoline acid derivatives |
02/10/2005 | US20050033055 Edg receptor agonists |
02/10/2005 | US20050032881 Novel non-psychotropic cannabinoids |
02/10/2005 | US20050032873 3-Amino chroman and 2-amino tetralin derivatives |
02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
02/10/2005 | US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
02/10/2005 | CA2534451A1 Angiotensin ii receptor blocker derivatives |
02/10/2005 | CA2534127A1 Substituted benzothiophene compounds and uses thereof |